4.5 Article

Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Radiology, Nuclear Medicine & Medical Imaging

Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS

Jianmin Ding et al.

Summary: This study compared the classification of liver nodules in high-risk hepatocellular carcinoma patients using CEUS and CECT/MRI LI-RADS, finding fair inter-modality agreement and comparable positive predictive values for HCC. CECT/MRI showed better diagnostic performance for non-HCC malignancy compared to CEUS.

EUROPEAN RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features

Hanyu Jiang et al.

Summary: The study aimed to develop diagnostic models for intrahepatic cholangiocarcinoma (M-CC) by combining serum tumor markers and LI-RADS imaging features, which showed high diagnostic performance for M-CC. Significant predictors of M-CC were identified as CA19-9, AFP, and absence of blood products in mass in LI-RADS, with their combination achieving high sensitivity and specificity.

EUROPEAN RADIOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade

Mei-Qing Cheng et al.

Summary: Pathological factors such as fibrosis stage and histological grade can influence the contrast-enhanced ultrasonography (CEUS) Liver Imaging Reporting and Data System (LI-RADS) classification in patients at high risk of hepatocellular carcinoma. Hepatic fibrosis stage may affect arterial phase hyperenhancement (APHE) but does not impact the CEUS LI-RADS classification, while the histological grade of HCC can influence LR-5 and LR-TIV categories.

EUROPEAN RADIOLOGY (2021)

Article Acoustics

MR VERSUS CEUS LI-RADS FOR DISTINGUISHING HEPATOCELLULAR CARCINOMA FROM OTHER HEPATIC MALIGNANCIES IN HIGH-RISK PATIENTS

Zhe Huang et al.

Summary: Distinguishing between other hepatic malignancies (OMs) and hepatocellular carcinoma (HCC) is crucial for optimal treatment and prognosis assessment in high-risk patients. This study compared the performance of MRI and CEUS LI-RADS in differentiating HCC from OMs and found that a modified CEUS LI-RADS system may improve diagnostic accuracy in high-risk HCC patients.

ULTRASOUND IN MEDICINE AND BIOLOGY (2021)

Article Oncology

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma

Kun Lv et al.

Summary: This study found that computed tomography/magnetic resonance imaging (CT/MRI) and contrast-enhanced ultrasound (CEUS) have good agreement in high-risk hepatocellular carcinoma (HCC) patients, but CT/MRI demonstrated higher specificity and positive predictive value in diagnosing HCC and non-HCC malignancies.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Can LI-RADS imaging features at gadoxetic acid-enhanced MRI predict aggressive features on pathology of single hepatocellular carcinoma?

Hong Wei et al.

EUROPEAN JOURNAL OF RADIOLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI

Sang Hyun Choi et al.

RADIOLOGY (2019)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Is It Time to Expand the Definition of Washout Appearance in LI-RADS?

Kathryn J. Fowler et al.

RADIOLOGY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma

Kathryn J. Fowler et al.

ABDOMINAL RADIOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group

Andrej Lyshchik et al.

ABDOMINAL RADIOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI

Stephanie R. Wilson et al.

ABDOMINAL RADIOLOGY (2018)

Article Gastroenterology & Hepatology

Role of Imaging in Surveillance and Diagnosis of Hepatocellular Carcinoma

Mohit Gupta et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients

Victoria Chernyak et al.

RADIOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection

Chansik An et al.

RADIOLOGY (2015)

Article Gastroenterology & Hepatology

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

Masao Omata et al.

HEPATOLOGY INTERNATIONAL (2010)